We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current HVO market cap is 194.08M. The company's latest EPS is EUR -0.0011 and P/E is -261.36.
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Revenue | 13.92M | 3.84M | 20.6M | 36.86M | 48.48M |
Operating Income | -4.61M | -5.72M | -10.61M | 492k | 5.98M |
Net Income | -4.78M | -6.54M | -10.79M | -74k | -776k |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Assets | 8.66M | 10.63M | 48.55M | 42.27M | 51.38M |
Total Liabilities | 4.3M | 7.28M | 26.25M | 21.59M | 31.16M |
Total Equity | 4.36M | 3.35M | 22.3M | 20.68M | 20.22M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Operating | -1.11M | -3.25M | 4.17M | -1.56M | 15.98M |
Investing | -104k | 487k | 1.18M | -739k | -1.36M |
Financing | 1.13M | 3.82M | 13.04M | -1.2M | -1.83M |
Market Cap | 194.08M |
Price to Earnings Ratio | -261.36 |
Price to Sales Ratio | 4 |
Price to Cash Ratio | 6.83 |
Price to Book Ratio | 9.6 |
Dividend Yield | - |
Shares Outstanding | 675.08M |
Average Volume (1 week) | 1.43M |
Average Volume (1 Month) | 2.01M |
52 Week Change | 56.46% |
52 Week High | 31.00 |
52 Week Low | 14.15 |
Spread (Intraday) | 0.5 (1.72%) |
Company Name | Hvivo Plc |
Address |
queen mary bioenterprises innovation centre london E1 2AX |
Website | https://www.hvivo.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions